Asia Pacific Chronic Cough Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Drug Class, Route of Administration, Distribution Channel, and Country

Publication Month: Aug 2020 | Report Code: TIPRE00013263 | No. of Pages: 153 | Category: Pharmaceuticals | Status: Published
Covid

The chronic cough market in Asia Pacific is expected to grow from US$ 1,136.66 million in 2019 to US$ 2,155.25 million by 2027. This represents a CAGR of 8.4% from 2020 to 2027.

The growth of the market in the region is expected to grow owing to rising incidences of chronic cough, growing product developments to treat chronic cough. Additionally, robust product pipeline, presence of major players and well-developed regulatory policies are projected to drive the Asia Pacific chronic cough market during the forecast period. 

The India has observed fast growth in the chronic cough market within the past few years and is expected to lead the market in Asia Pacific during the forecast period.Chronic cough is defined as a persistent cough that lasts long up to 6-8 weeks. It significantly affects the life of the patients by interrupt sleeping, vomiting, light-headedness, and even rib fractures. Developing countries have to bear the burden of both communicable and noncommunicable diseases simultaneously. The recent Global Burden of Disease (GBD) survey data have shown that both acute and chronic respiratory diseases are prevalent in substantial number in India. Chronic respiratory diseases, especially asthma and chronic obstructive pulmonary disease (COPD), are of particular importance for having wide variations in morbidity and mortality in various Indian states. There were 28.1 million cases of COPD in India in 1990; this increased to 55.3 million in 2016, showed a September 2018 study published in The Lancet Global Health. India has 18% of the world’s population but 32% of its COPD burden; it further showed Chronic Obstructive Pulmonary Disease (COPD) was the second-highest cause of death in India after heart disease in 2017, killing 1 million (958,000) Indians that year, according to University of Washington’s Global Burden of Disease study, 2018.

India Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)

India Chronic Cough Market Revenue and Forecast to 2027 (US$ Million)

Get more information on this report :


 

 

ASIA PACIFICCHRONIC COUGH – MARKET SEGMENTATION

By Drug Class

  • Antihistamines
  • Corticosteroids
  • Decongestants
  • Combination Drug
  • Antibiotics
  • Acid Blockers
  • Other Drug Class

By Route of Administration

  • Oral
  • Injections
  • Nasal
  • Other Route of Administration

By Distribution Channel

  • Hospital Pharmacy
  • Online Pharmacy
  • Retail Pharmacy

By Country

  • Japan
  • China
  • India
  • South Korea
  • Australia

Company Profiles

  • Novartis AG
  • Teva Pharmaceutical Industries Ltd
  • GlaxoSmithKline plc.
  • Bayer AG
  • Mylan N.V.
  • Amneal Pharmaceuticals, Inc.
  • Cipla Inc.
  • Reckitt Benckiser Group plc.
  • Sun Pharmaceutical Industries Ltd
  • Aurobindo Pharma Ltd

1.           Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1        Chronic Cough Market – By Drug Class

1.3.2        Chronic Cough Market – By Route of Administration

1.3.3        Chronic Cough Market – By Distribution Channel

1.3.4        Chronic Cough Market – By Country

2.           Chronic Cough Market – Key Takeaways

3.           Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.           Asia Pacific Chronic Cough Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.3         Expert Opinion

5.           Asia Pacific Chronic Cough Market – Key Market Dynamics

5.1         Market Drivers

5.1.1        Rising Incidences of Chronic Cough

5.1.2        Growing Product Developments to Treat Chronic Cough

5.2         Market Restraints

5.2.1        Product Recalls

5.3         Market Opportunities

5.3.1        Aging Population is Expected to Drive Demand for Chronic Cough Treatment

5.4         Future Trends

5.4.1        Continuous Trend of Drug Development

5.5         Impact Analysis

6.           Asia Pacific Chronic Cough Market Analysis – By Drug Class

6.1         Overview

6.2         Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

6.3         Antihistamines

6.3.1        Overview

6.3.2        Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.4         Corticosteroids

6.4.1        Overview

6.4.2        Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.5         Decongestants

6.5.1        Overview

6.5.2        Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.6         Combination Drug

6.6.1        Overview

6.6.2        Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.7         Antibiotics

6.7.1        Overview

6.7.2        Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.8         Acid Blockers

6.8.1        Overview

6.8.2        Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

6.9         Other Drug Class

6.9.1        Overview

6.9.2        Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.           Asia Pacific Chronic Cough Market – By Route of Administration

7.1         Overview

7.2         Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

7.3         Oral

7.3.1        Overview

7.3.2        Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.4         Injections

7.4.1        Overview

7.4.2        Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.5         Inhalation

7.5.1        Overview

7.5.2        Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

7.6         Other Route of Administration

7.6.1        Overview

7.6.2        Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.           Asia Pacific Chronic Cough Market – By Distribution Channel

8.1         Overview

8.2         Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

8.3         Hospital Pharmacy

8.3.1        Overview

8.3.2        Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.4         Online Pharmacy

8.4.1        Overview

8.4.2        Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

8.5         Retail Pharmacy

8.5.1        Overview

8.5.2        Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

9.           Asia Pacific Chronic Cough Market – Country Analysis

9.1         Asia Pacific: Chronic Cough Market

9.1.1        Overview

9.1.2        Asia Pacific: Chronic Cough Market - Revenue and Forecast to 2027 (USD Million)

9.1.3        Asia Pacific: Chronic Cough Market, by Drug Class, 2018–2027 (USD Million)

9.1.4        Asia Pacific: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.5        Asia Pacific: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.6        Asia Pacific: Chronic Cough Market, by Country, 2019 & 2027 (%)

9.1.7        China: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.1          China: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.7.2          China: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.7.3          China: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.7.4          China: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.8        Japan: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.1          Japan: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.8.2          Japan: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.8.3          Japan: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.8.4          Japan: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.9        India: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.1          India: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.9.2          India: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.9.3          India: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.9.4          India: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.10     South Korea: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.1       South Korea: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.10.2       South Korea: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.10.3       South Korea: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.10.4       South Korea: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

9.1.11     Australia: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.1       Australia: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

9.1.11.2       Australia: Chronic Cough Market, by Drug Class , 2018–2027 (USD Million)

9.1.11.3       Australia: Chronic Cough Market, by Route of Administration , 2018–2027 (USD Million)

9.1.11.4       Australia: Chronic Cough Market, by Distribution Channel , 2018–2027 (USD Million)

10.        Impact of COVID-19 Pandemic on Asia Pacific Chronic cough Market

10.1      Impact Assessment of COVID-19 Pandemic

11.        COMPANY PROFILES

11.1      Novartis AG

11.1.1     Key Facts

11.1.2     Business Description

11.1.3     Products and Services

11.1.4     Financial Overview

11.1.5     SWOT Analysis

11.1.6     Key Developments

11.2      TEVA PHARMACEUTICAL INDUSTRIES LTD

11.2.1     Key Facts

11.2.2     Business Description

11.2.3     Products and Services

11.2.4     Financial Overview

11.2.5     SWOT Analysis

11.2.6     Key Developments

11.3      GlaxoSmithKline plc.

11.3.1     Key Facts

11.3.2     Business Description

11.3.3     Products and Services

11.3.4     Financial Overview

11.3.5     SWOT Analysis

11.3.6     Key Developments

11.4      Bayer AG

11.4.1     Key Facts

11.4.2     Business Description

11.4.3     Products and Services

11.4.4     Financial Overview

11.4.5     SWOT Analysis

11.4.6     Key Developments

11.5      MYLAN N.V.

11.5.1     Key Facts

11.5.2     Business Description

11.5.3     Products and Services

11.5.4     Financial Overview

11.5.5     SWOT Analysis

11.5.6     Key Developments

11.6      Amneal Pharmaceuticals, Inc.

11.6.1     Key Facts

11.6.2     Business Description

11.6.3     Products and Services

11.6.4     Financial Overview

11.6.5     SWOT Analysis

11.6.6     Key Developments

11.7      Cipla Inc.

11.7.1     Key Facts

11.7.2     Business Description

11.7.3     Products and Services

11.7.4     Financial Overview

11.7.5     SWOT Analysis

11.7.6     Key Developments

11.8      Reckitt Benckiser Group plc.

11.8.1     Key Facts

11.8.2     Business Description

11.8.3     Products and Services

11.8.4     Financial Overview

11.8.5     SWOT Analysis

11.8.6     Key Developments

11.9      Sun Pharmaceutical Industries Ltd

11.9.1     Key Facts

11.9.2     Business Description

11.9.3     Products and Services

11.9.4     Financial Overview

11.9.5     SWOT Analysis

11.9.6     Key Developments

11.10   Aurobindo Pharma Ltd

11.10.1  Key Facts

11.10.2  Business Description

11.10.3  Products and Services

11.10.4  Financial Overview

11.10.5  SWOT Analysis

11.10.6  Key Developments

12.        Appendix

12.1      Glossary of Terms

LIST OF TABLES

Table 1.             Asia Pacific Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 2.             Asia Pacific Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 3.             Asia Pacific Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 4.             China Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 5.             China Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 6.             China Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 7.             Japan Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 8.             Japan Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 9.             Japan Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 10.          India Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 11.          India Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 12.          India Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 13.          South Korea Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 14.          South Korea Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 15.          South Korea Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 16.          Australia Chronic Cough Market, by Drug Class – Revenue and Forecast to 2027 (USD Million)

Table 17.          Australia Chronic Cough Market, by Route of Administration– Revenue and Forecast to 2027 (USD Million)

Table 18.          Australia Chronic Cough Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 19.          Glossary of Terms, Chronic Cough Market

LIST OF FIGURES

Figure 1.           Chronic Cough Market Segmentation

Figure 2.           Chronic Cough Market – By Country

Figure 3.           Asia Pacific Chronic Cough Market Overview

Figure 4.           Combination Drug Segment Held Largest Share of Chronic Cough Market

Figure 5.           Asia Pacific to Show Remarkable Growth During Forecast Period

Figure 6.           Asia Pacific PEST Analysis

Figure 7.           Expert Opinion

Figure 8.           Chronic Cough Market Impact Analysis of Drivers and Restraints

Figure 9.           Chronic Cough Market Revenue Share, by Drug Class (2019 and 2027)

Figure 10.        Antihistamines: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 11.        Corticosteroids: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 12.        Decongestants: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 13.        Combination Drug: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 14.        Antibiotics: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 15.        Acid Blockers: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 16.        Other Drug Class: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 17.        Chronic Cough Market, by Route of Administration, 2019 and 2027 (%)

Figure 18.        Oral: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 19.        Injections: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 20.        Inhalation: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 21.        Other Route of Administration: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 22.        Chronic Cough Market, by Distribution Channel, 2019 and 2027 (%)

Figure 23.        Hospital Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 24.        Online Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 25.        Retail Pharmacy: Chronic Cough Market – Revenue and Forecast to 2027 (US$ Million)

Figure 26.        Asia Pacific: Chronic Cough Market, by Key Country – Revenue (2019) (USD Million)

Figure 27.        Asia Pacific Chronic Cough Market Revenue and Forecast to 2027 (USD Million)

Figure 28.        China: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.        Japan: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 30.        India: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 31.        South Korea: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 32.        Australia: Chronic Cough Market – Revenue and Forecast to 2027 (USD Million)

Figure 33.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

 

  1. Novartis AG
  2. Teva Pharmaceutical Industries Ltd
  3. GlaxoSmithKline plc.
  4. Bayer AG
  5. Mylan N.V.
  6. Amneal Pharmaceuticals, Inc.
  7. Cipla Inc.
  8. Reckitt Benckiser Group plc.
  9. Sun Pharmaceutical Industries Ltd
  10. Aurobindo Pharma Ltd.
  • To understand the Asia Pacific Chronic Cough marketlandscape and identifymarket segments that are most likely to guarantee a strong return.

  • To stay ahead incomprehending the ever-changing competitive landscape of theAsia Pacific Chronic Cough market.

  • To efficiently plan M&A and partnership dealsin the Asia Pacific Chronic Cough marketby identifying market segments with the most promising probable sales.

  • To help takeknowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segmentsinthe Asia Pacific Chronic Cough market.

  • To obtain market revenue forecast from 2019 to 2027 in various segmentsofthe Asia Pacific Chronic Cough market.
TIPRE00013263
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing